Sirius Business: Cryer Acquisition

[Cryer Pharm. Inc.]

[830 A.S]

Join us today for another episode of Sirius Business, where Eliza Joy covers the recent acquisition of Cryer Pharmaceuticals by a young aspiring billionaire, after almost a year of the company laying low without any progress in their fields of research.
Coming up next on the Colony News Service channel 9.

---

---

---

All the news that's fit for you, this is the Colony News Service

---

---

---

Cryer Pharmaceuticals, known for manufacturing most, if not all of the medicine available throughout the Sirius sector, has been laying very low with their research projects since their unsuccessful attempt to expand Atka Research Station. With stock prices drastically dropping, the company has been recently acquired by the aspiring young billionaire Kilian A. Queen. Does that signify a new start for the company's business endeavors?

I'm Eliza Joy, and this is Sirius Business.

---

Eliza Joy
Show Hostess @ Sirius Business

With us on the comm line are two of the company's most influential chairmen: Business Manager Sir Donnel Bucksworth, and Head of Research Dr. Persimony Felcher.

Sir Donnel Bucksworth
Business Manager @ Cryer Pharmaceuticals Inc.

Thank you so much for having us on the show, Eliza dear! It's a pleasure to be here.

Dr. Persimony Felcher
Head of Research @ Cryer Pharmaceuticals Inc.

Real pleasure indeed. Thank you.

Eliza Joy
Show Hostess @ Sirius Business

The pleasure is all mine, gentlemen. Now, tell me, what has Cryer been up to in the recent year? Why have you guys gone under the radar for so long?

Dr. Persimony Felcher
Head of Research @ Cryer Pharmaceuticals Inc.

Well, we haven't really stopped anything we were doing, it's just-

Sir Donnel Bucksworth
Business Manager @ Cryer Pharmaceuticals Inc.

Dr. Felcher, I'll take it from here please. Thank you.
Well, as you probably know, a successful business must take risks to remain successful. The expansion of Atka was a major risk we had to take, albeit an unfortunate one. The failure of this project led to a chain of unfortunate events bringing many of our operations to a halt, including the diminishing of Stabiline supply despite high demand. Without restoring Atka to its full capacity, it's hard to maintain a high production rate.

Eliza Joy
Show Hostess @ Sirius Business

So the failure of the Atka expansion was a catastrophic event for the corporation, I get it. But what about the other projects? You had ongoing advancements with the Crayter Republic, and a business venture on Planet Curacao.

Sir Donnel Bucksworth
Business Manager @ Cryer Pharmaceuticals Inc.

Ah yes, our research lab on Curacao is still alive and kicking. The "Borneo Project" however never kicked off. We never agreed on the terms of the contract. Quite a shame actually, it seemed like an interesting opportunity for both parties.

Dr. Persimony Felcher
Head of Research @ Cryer Pharmaceuticals Inc.

Actually, now when we have more funds, we might reinitiate this project along with some others. Before you ask, I'm in no position to share more details unfortunately. Apologies.

Eliza Joy
Show Hostess @ Sirius Business

Speaking of funds, how are you both finding the new owner? I gather it's like a breath of fresh air for your departments, is it not?

Dr. Persimony Felcher
Head of Research @ Cryer Pharmaceuticals Inc.

Oh, definitely! That's exactly the kind of change I've been waiting for. Finally, I'm able to promote long-awaited research projects that haven't seen the light of day.

Sir Donnel Bucksworth
Business Manager @ Cryer Pharmaceuticals Inc.

It's a welcome change indeed, and what a fine guy Mr. Queen is! Good looking as well, I must add. Though, honestly, I still need to get used to the fact this company is owned by someone so much younger than myself! [chuckles]

Eliza Joy
Show Hostess @ Sirius Business

Would you say that the wind of change blows strong enough for you to attempt the Atka expansion a second time?

Sir Donnel Bucksworth
Business Manager @ Cryer Pharmaceuticals Inc.

At this time, I really can't say. Not because my lips are sealed, but because it's a conflict between the ever-rising demand for Stabiline and our values as a company. Many lives were lost in the incident, and a lot of money went down the drain. We wouldn't want to make such risks again.

Eliza Joy
Show Hostess @ Sirius Business

Thank you so much gentlemen, that'd be all for now.
We'll be right back after a short commercial break with more details on Cryer's new owner, Mr. Kilian A Queen. Did he take a risk acquiring the majority of Cryer stocks? What's his plan for the pharma giant's future? All that an more, right here on Sirius Business. Stay with us.

---

Discord <><><> Information <><><> Recruitement <><><> Feedback <><><> Internal Message Database